<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mar Drugs</journal-id><journal-id journal-id-type="iso-abbrev">Mar Drugs</journal-id><journal-id journal-id-type="publisher-id">marinedrugs</journal-id><journal-title-group><journal-title>Marine Drugs</journal-title></journal-title-group><issn pub-type="epub">1660-3397</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6356697</article-id><article-id pub-id-type="doi">10.3390/md17010030</article-id><article-id pub-id-type="publisher-id">marinedrugs-17-00030</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Purification and Characterization of a Novel Pentadecapeptide from Protein Hydrolysates of <italic>Cyclina sinensis</italic> and Its Immunomodulatory Effects on RAW264.7 Cells</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Li</surname><given-names>Wei</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ye</surname><given-names>Shengwang</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0310-6607</contrib-id><name><surname>Zhang</surname><given-names>Zhuangwei</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tang</surname><given-names>Jiachao</given-names></name></contrib><contrib contrib-type="author"><name><surname>Jin</surname><given-names>Huoxi</given-names></name></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Fangfang</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Zuisu</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4450-2956</contrib-id><name><surname>Tang</surname><given-names>Yunping</given-names></name><xref rid="c1-marinedrugs-17-00030" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Yan</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ding</surname><given-names>Guofang</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4352-4264</contrib-id><name><surname>Yu</surname><given-names>Fangmiao</given-names></name><xref rid="c1-marinedrugs-17-00030" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-marinedrugs-17-00030">Zhejiang Provincial Engineering Technology Research Center of Marine Biomedical Products, School of Food and Pharmacy, Zhejiang Ocean University, Zhoushan 316022, China; <email>liweizjou@163.com</email> (W.L.); <email>yesw1003@163.com</email> (S.Y.); <email>all_zzw@163.com</email> (Z.Z.); <email>T1528358025@163.com</email> (J.T.); <email>jinhuoxi@163.com</email> (H.J.); <email>gracegang@126.com</email> (F.H.); <email>abc1967@126.com</email> (Z.Y.); <email>cyancy@zjou.edu.cn</email> (Y.C.); <email>dinggf2007@163.com</email> (G.D.)</aff><author-notes><corresp id="c1-marinedrugs-17-00030"><label>*</label>Correspondence: <email>tangyunping1985@163.com</email> (Y.T.); <email>fmyu@zjou.edu.cn</email> (F.Y.); Tel.: +86-0580-226-0600 (F.Y.); Fax: +86-0580-818-6396 (F.Y.)</corresp></author-notes><pub-date pub-type="epub"><day>06</day><month>1</month><year>2019</year></pub-date><pub-date pub-type="collection"><month>1</month><year>2019</year></pub-date><volume>17</volume><issue>1</issue><elocation-id>30</elocation-id><history><date date-type="received"><day>10</day><month>12</month><year>2018</year></date><date date-type="accepted"><day>01</day><month>1</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 by the authors.</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>In the present study, peptide fractions of <italic>Cyclina sinensis</italic> hydrolysates, with molecular weight (MW) &#x0003c; 3 kDa and highest relative proliferation rate of murine macrophage cell line RAW 264.7, were purified by a series of chromatographic purification methods, to obtain peptide fractions with immunomodulatory activity. The amino acid sequence of the peptide was identified to be Arg-Val-Ala-Pro-Glu-Glu-His-Pro-Val-Glu-Gly-Arg-Tyr-Leu-Val (RVAPEEHPVEGRYLV) with MW of 1750.81 Da, and the novel pentadecapeptide (named SCSP) was synthesized for subsequent immunomodulatory activity experiments. Results showed the SCSP enhanced macrophage phagocytosis, increased productions of nitric oxide (NO), tumor necrosis factor-&#x003b1; (TNF-&#x003b1;), interleukin-6 (IL-6), and interleukin-1&#x003b2; (IL-1&#x003b2;), and up-regulated the protein level of inducible nitric oxide synthase (iNOS), nuclear factor &#x003ba;B (NF-&#x003ba;B), and NOD-like receptor protein 3 (NLRP3) in RAW 264.7 cells. Furthermore, the expression of inhibitor of nuclear factor &#x003ba;B-&#x003b1; (I&#x003ba;B-&#x003b1;) was down-regulated. These findings suggest that SCSP might stimulate macrophage activities by activating the NF-&#x003ba;B signaling pathway and can be used as a potential immunomodulatory agent in functional food or medicine.</p></abstract><kwd-group><kwd><italic>Cyclina sinensis</italic></kwd><kwd>protein hydrolysates</kwd><kwd>immunomodulatory peptides</kwd><kwd>RAW264.7 cell</kwd></kwd-group></article-meta></front><body><sec id="sec1-marinedrugs-17-00030"><title>1. Introduction</title><p>The immune system plays a crucial role in maintaining human health by identifying and killing pathogens, aging cells, and tumor cells. Its functions can be affected by many factors, including social pressure, negative emotion, unhealthy lifestyle, and presence of pathogens [<xref rid="B1-marinedrugs-17-00030" ref-type="bibr">1</xref>]. Macrophages are vital immune cells that participate in both non-specific (innate immunity) and specific defense (cellular immunity) in vertebrates. Activated macrophages have been reported to directly kill and eliminate pathogens, necrotic cell fragments, and foreign substances via phagocytosis, and indirectly participate in immune regulation through the secretion and release of pro-inflammatory cytokines (TNF-&#x003b1;, IL-6, and IL-1&#x003b2;) and inflammatory molecules (reactive oxygen species (ROS), NO) [<xref rid="B2-marinedrugs-17-00030" ref-type="bibr">2</xref>] Macrophage activation is considered a promising strategy for enhancing host immune function. Currently, several drugs such as levamisole, imiquimod, pidotimod, tilorone, and cyclosporine are being clinically used for regulating human immune function. However, most immunomodulating drugs synthesized microbially or chemically, exhibit toxicity and side effects, which limits their usage in the prevention and treatment of chronic diseases [<xref rid="B3-marinedrugs-17-00030" ref-type="bibr">3</xref>]. Dietary therapy is considered an effective strategy for regulating immune function, as naturally derived immunomodulatory peptides do not show side effects.</p><p>Bioactive peptides (consisting of 2&#x02013;20 amino acids) are protein fragments released from protein molecules via enzymatic hydrolysis and a series of refining processes, which harbor multiple bioactivities, including immunomodulatory [<xref rid="B4-marinedrugs-17-00030" ref-type="bibr">4</xref>], anti-inflammatory [<xref rid="B5-marinedrugs-17-00030" ref-type="bibr">5</xref>], antihypertensive [<xref rid="B6-marinedrugs-17-00030" ref-type="bibr">6</xref>,<xref rid="B7-marinedrugs-17-00030" ref-type="bibr">7</xref>,<xref rid="B8-marinedrugs-17-00030" ref-type="bibr">8</xref>], anticancer [<xref rid="B9-marinedrugs-17-00030" ref-type="bibr">9</xref>], antioxidant [<xref rid="B10-marinedrugs-17-00030" ref-type="bibr">10</xref>,<xref rid="B11-marinedrugs-17-00030" ref-type="bibr">11</xref>], and antifatigue [<xref rid="B12-marinedrugs-17-00030" ref-type="bibr">12</xref>] activities. Recently, several immunomodulatory peptides have been purified and identified from protein hydrolysates of natural origin [<xref rid="B13-marinedrugs-17-00030" ref-type="bibr">13</xref>]. Three immunomodulating peptides, Asn-Gly-Met-Thr-Tyr, Asn-Gly-Leu-Ala-Pro, and Trp-Thr, isolated from enzymatic hydrolysates of Alaska Pollock frame enhanced lymphocyte proliferation [<xref rid="B14-marinedrugs-17-00030" ref-type="bibr">14</xref>]. Wu, et al. [<xref rid="B15-marinedrugs-17-00030" ref-type="bibr">15</xref>] isolated a novel hexapeptide (Glu-Cys-Phe-Ser-Thr-Ala) from wheat germ globulin, which showed significant immunomodulatory effects on RAW 264.7 macrophages. However, few immunomodulatory peptides have been purified from proteins of crustaceans and mollusks.</p><p><italic>Cyclina sinensis</italic>, a marine bivalve mollusk, widely cultured along the mud-sandy coasts of China, has been used for treatment of asthma, dental ulcers, and inflammation in Chinese traditional medicine [<xref rid="B16-marinedrugs-17-00030" ref-type="bibr">16</xref>,<xref rid="B17-marinedrugs-17-00030" ref-type="bibr">17</xref>]. Furthermore, <italic>Cyclina sinensis</italic> is rich in protein and polysaccharides [<xref rid="B17-marinedrugs-17-00030" ref-type="bibr">17</xref>], which may contribute to its biological properties, such as anti-cancer, immunomodulatory, antioxidant, and hepatoprotective activities [<xref rid="B18-marinedrugs-17-00030" ref-type="bibr">18</xref>,<xref rid="B19-marinedrugs-17-00030" ref-type="bibr">19</xref>,<xref rid="B20-marinedrugs-17-00030" ref-type="bibr">20</xref>,<xref rid="B21-marinedrugs-17-00030" ref-type="bibr">21</xref>]. Zhang, et al. [<xref rid="B22-marinedrugs-17-00030" ref-type="bibr">22</xref>] observed that <italic>Cyclina sinensis</italic> flesh extracts stimulated immune response and enhanced body resistance by increasing the activity of acid-naphthyl acetate esterase (ANAE) in macrophages and lymphocytes in aged mice. Yu, et al. [<xref rid="B23-marinedrugs-17-00030" ref-type="bibr">23</xref>] isolated a novel anti-proliferative pentapeptide (Ile-Leu-Tyr-Met-Pro) from protein hydrolysates of <italic>Cyclina sinensis</italic>, which induced apoptosis of DU-145 prostate cancer cells. The <italic>Cyclina sinensis</italic> -derived angiotensin-I converting enzyme (ACE) inhibitory peptide WPMGF (Trp-Pro-Met-Gly-Phe, 636.75 Da) shows potent ACE inhibitory activity with relatively stable physiological activity under different temperatures, pH, and simulated gastrointestinal digestion [<xref rid="B8-marinedrugs-17-00030" ref-type="bibr">8</xref>].</p><p>Previously, we have shown that pepsin hydrolysates of <italic>Cyclina sinensis</italic> with MW &#x0003c; 3 kDa significantly promoted the proliferation of RAW 264.7 murine macrophages [<xref rid="B21-marinedrugs-17-00030" ref-type="bibr">21</xref>]. However, the amino acid sequence of the immunomodulatory peptide was not confirmed, nor was its immunomodulatory effect accurately evaluated. Therefore, in this study, the protein hydrolysates of <italic>Cyclina sinensis</italic> with MW &#x0003c; 3 kDa were purified using chromatographic methods, and the amino acid sequence of the immunomodulatory peptide was identified using Edman degradation and electrospray ionization (ESI) mass analyses. The immunomodulatory activity on RAW 264.7 murine macrophages was evaluated for determining its capacity for phagocytosis, secretion of NO, TNF-&#x003b1;, IL-1&#x003b2;, and IL-6 was assayed, and the protein levels of iNOS, I&#x003ba;B-&#x003b1;, NF-&#x003ba;B, and NLRP3 were determined using western blotting. Our results indicated that SCSP can be potentially used as an immunotherapeutic adjuvant in functional food or medicine.</p></sec><sec id="sec2-marinedrugs-17-00030"><title>2. Results and Discussion</title><sec id="sec2dot1-marinedrugs-17-00030"><title>2.1. Purification of Activity Peptide</title><p>DEAE Sepharose Fast Flow is a weak anion exchanger, and fractions with positive charges are eluted first when the hydrolysates are bonded to the exchangers [<xref rid="B24-marinedrugs-17-00030" ref-type="bibr">24</xref>]. Kong et al. [<xref rid="B25-marinedrugs-17-00030" ref-type="bibr">25</xref>] reported that higher content of positively charged peptides effectively stimulates immunomodulatory activity and is positive correlations. The ion-exchange chromatogram is shown in <xref ref-type="fig" rid="marinedrugs-17-00030-f001">Figure 1</xref>a. The cell proliferative properties of the four fractions (IEC-I, IEC-II, IEC-III, and IEC-IV) obtained from the fraction with MW &#x0003c; 3 kDa based on its charge properties were determined at concentrations of 100 &#x003bc;g/mL. The relative proliferative rate of IEC-I (90.9 &#x000b1; 3.8%) was twice of that IEC-II (35.2 &#x000b1; 4.0%), IEC-III (36.6 &#x000b1; 3.5%), and IEC-IV (44.4 &#x000b1; 2.3%) towards RAW 264.7 cells (<xref ref-type="fig" rid="marinedrugs-17-00030-f001">Figure 1</xref>b). Thus, peak IEC-I was selected for further purification using Gel-25 filtration chromatography.</p><p>Gel filtration (size exclusion) chromatography excludes high MW fractions from cross-linked agarose, which are first eluted and separated. The low MW fraction enters the interior and is subsequently separated [<xref rid="B26-marinedrugs-17-00030" ref-type="bibr">26</xref>]. IEC-I was fractioned into three subfractions of GFC-I, GFC-II, and GFC-III (<xref ref-type="fig" rid="marinedrugs-17-00030-f001">Figure 1</xref>c) by the Sephadex G-25 gel filtration column and cell proliferative rates were determined at concentrations of 100 &#x003bc;g/mL. GFC-II possessed higher cell proliferative rate (98.9 &#x000b1; 2.7%) toward RAW 264.7 cells than GFC-I (60.8 &#x000b1; 0.3%) and GFC-III (37.1 &#x000b1; 1.7%) (<xref ref-type="fig" rid="marinedrugs-17-00030-f001">Figure 1</xref>d). A previous study also confirmed that immune cell proliferation correlated with the MW of peptides [<xref rid="B25-marinedrugs-17-00030" ref-type="bibr">25</xref>].</p><p>The GFC-II fraction was further purified in an RP-HPLC system, the elution profile of which is shown in <xref ref-type="fig" rid="marinedrugs-17-00030-f002">Figure 2</xref>a. Fractions HPLC-I, HPLC-II, and HPLC-IV were separately collected and lyophilized for measurement of cell proliferation rate. Owing to the low content of HPLC-III and HPLC-V, minor fractions from small peaks were not collected. Fraction HPLC-IV (98.16 &#x000b1; 2.9%) not only possessed higher immunomodulatory activity, but also higher content than HPLC-I (38.2 &#x000b1; 1.5%) and HPLC-II (33.4 &#x000b1; 2.1%) (<xref ref-type="fig" rid="marinedrugs-17-00030-f002">Figure 2</xref>b). Thus, HPLC-IV was collected for purity testing and determination of amino acid sequences</p></sec><sec id="sec2dot2-marinedrugs-17-00030"><title>2.2. Analysis of Peptide Purity and Peptide Sequencing</title><p>Only one peak was obtained in the elution profile of the HPLC-IV fraction during purity analysis (<xref ref-type="fig" rid="marinedrugs-17-00030-f003">Figure 3</xref>), which was collected, lyophilized, and named CSP. The amino acid sequence of the purified peptide CSP was determined to be Arg-Val-Ala-Pro-Glu-Glu- His-Pro-Val-Glu-Gly-Arg-Tyr-Leu-Val (RVAPEEHPVEGRYLV) with a MW of 1750.78 Da ([M&#x02212;H]&#x02212;, <xref ref-type="fig" rid="marinedrugs-17-00030-f004">Figure 4</xref>), which was consistent with a theoretical mass of 1750.96 Da. Hydrophobicity is an important physical property of proteins. Some studies have demonstrated that hydrophobic values can effectively contribute to the immunomodulatory activity of peptides [<xref rid="B27-marinedrugs-17-00030" ref-type="bibr">27</xref>,<xref rid="B28-marinedrugs-17-00030" ref-type="bibr">28</xref>]. This may be due to an increase in the interaction of the peptide and cell membrane, which improves immune regulation [<xref rid="B29-marinedrugs-17-00030" ref-type="bibr">29</xref>]. In addition, a terminal rich in basic or hydrophobic amino acids can also be considered as an indicator of immunomodulatory activity [<xref rid="B15-marinedrugs-17-00030" ref-type="bibr">15</xref>,<xref rid="B29-marinedrugs-17-00030" ref-type="bibr">29</xref>,<xref rid="B30-marinedrugs-17-00030" ref-type="bibr">30</xref>]. In this novel pentadecapeptide, the carboxy (-Arg-Tyr-Leu-Val) and amino termini (Arg-Val-Ala-Pro-) have basic and hydrophobic amino acids, respectively, and these characteristics may contribute to immunomodulatory activity.</p></sec><sec id="sec2dot3-marinedrugs-17-00030"><title>2.3. Immunomodulatory Effects of SCSP</title><sec id="sec2dot3dot1-marinedrugs-17-00030"><title>2.3.1. Effect of SCSP on Macrophage Viability</title><p>Activated macrophages play critical roles in cell-mediated and humoral immunity. They first remove necrotic debris from tissues and cells at the site of injury via phagocytosis and then produce NO to directly kill the pathogen. Various cytokines and enzymes are secreted simultaneously, which participate in the inflammatory reaction and guide the process of body repair [<xref rid="B31-marinedrugs-17-00030" ref-type="bibr">31</xref>]. Therefore, macrophage viability can be used as an indicator of immunomodulatory effects and toxicity of an immune activator. The toxic effects on RAW 264.7 cells were examined using the MTT viability assay prior to investigating the immunomodulatory activity of SCSP. The results of the MTT assay (<xref ref-type="fig" rid="marinedrugs-17-00030-f005">Figure 5</xref>) showed that SCSP treatment of promoted RAW 264.7 cell proliferation to a certain degree, indicating that the macrophages were activated. Compared to the control, 6.25&#x02013;50 &#x003bc;g/mL SCSP significantly increased the viability of macrophages in a dose-dependent manner (<italic>P</italic> &#x0003c; 0.05). The relative proliferation activity of the cells showed a slight decrease when the concentration of SCSP was &#x02265; 100 &#x003bc;g/mL, indicating that high concentrations of SCSP showed slight cytotoxic effect on RAW 264.7 cells. The cytotoxicity exhibited by high concentrations of immunomodulators has also been reported [<xref rid="B32-marinedrugs-17-00030" ref-type="bibr">32</xref>,<xref rid="B33-marinedrugs-17-00030" ref-type="bibr">33</xref>]. Therefore, we treated RAW 264.7 cells with 12.5&#x02013;50 &#x003bc;g/mL SCSP during subsequent experiments.</p></sec><sec id="sec2dot3dot2-marinedrugs-17-00030"><title>2.3.2. Effect of SCSP on Phagocytosis</title><p>Phagocytosis is important for specific and non-specific immunity, clearance of senescent or apoptotic cells and necrotic tissue fragments, and processes related to host defense and autoimmunity [<xref rid="B34-marinedrugs-17-00030" ref-type="bibr">34</xref>]. One of the most striking features of activated macrophages is the uptake of exogenous particles via phagocytosis [<xref rid="B35-marinedrugs-17-00030" ref-type="bibr">35</xref>]. Therefore, in the present study, we determined the effect of SCSP on the phagocytic activity of RAW 264.7 cells by constructing a model of neutral red dye internalization by macrophages. As shown in <xref ref-type="fig" rid="marinedrugs-17-00030-f006">Figure 6</xref>, all phagocytosis indices of SCSP exceeded 1.0 and increased in a dose-dependent manner at various concentrations. The phagocytosis index reached 2.20 at the SCSP concentration of 50 &#x003bc;g/mL, which was slightly lower than that induced by 1 &#x003bc;g/mL LPS (2.32). In a previous study, Huang et al. [<xref rid="B36-marinedrugs-17-00030" ref-type="bibr">36</xref>] observed that oviductus ranae hydrolysate prepared with a neutral protease significantly regulated macrophage phagocytosis in a dose-dependent manner, and similar phagocytic activity was also observed in wheat germ globulin [<xref rid="B15-marinedrugs-17-00030" ref-type="bibr">15</xref>], Alaska pollock frame [<xref rid="B37-marinedrugs-17-00030" ref-type="bibr">37</xref>], and oyster (<italic>Crassostrea gigas</italic>) hydrolysates [<xref rid="B3-marinedrugs-17-00030" ref-type="bibr">3</xref>]. These data indicate that SCSP was able to enhance the phagocytic activity of macrophages in a dose-dependent manner.</p></sec><sec id="sec2dot3dot3-marinedrugs-17-00030"><title>2.3.3. Effect of SCSP on NO Production and iNOS Expression</title><p>NO acts as a key messenger molecule for activated macrophages and plays an important role in immune regulation. It not only protects against exogenous pathogens and tumor cells, but also regulates cellular activities associated with the immune system [<xref rid="B38-marinedrugs-17-00030" ref-type="bibr">38</xref>]. Mammalian NO synthase (NOS) has three different isoforms: neuronal (nNOS), inducible (iNOS), and endothelial (eNOS). iNOS is easily induced and expressed in activated macrophages and is the most important enzyme in NO synthesis [<xref rid="B39-marinedrugs-17-00030" ref-type="bibr">39</xref>,<xref rid="B40-marinedrugs-17-00030" ref-type="bibr">40</xref>]. Hence, we assessed macrophage activation by measuring NO secretion in SCSP-treated macrophages. The protein level of iNOS was also analyzed using western bloting. As shown in <xref ref-type="fig" rid="marinedrugs-17-00030-f007">Figure 7</xref>a, SCSP stimulated NO production in RAW 264.7 cells in a dose-dependent manner. At low concentrations (25 &#x003bc;g/mL), SCSP did not significantly affect NO production. However, NO production was significantly stimulated in RAW 264.7 cells at both medium (50 &#x003bc;g/mL, <italic>P</italic> &#x0003c; 0.05) and high doses (100 &#x003bc;g/mL, <italic>P</italic> &#x0003c; 0.01). In addition, the protein levels of iNOS increased remarkably after SCSP treatment (<italic>P</italic> &#x0003c; 0.05) (<xref ref-type="fig" rid="marinedrugs-17-00030-f007">Figure 7</xref>b). These results demonstrated that SCSP up-regulated the protein levels of iNOS and NO secretion in RAW 264.7 cells in a dose-dependent manner, which is consistent with that previously demonstrated for oviductus ranae [<xref rid="B36-marinedrugs-17-00030" ref-type="bibr">36</xref>], yellow field pea seeds [<xref rid="B41-marinedrugs-17-00030" ref-type="bibr">41</xref>] and Coix glutelin protein hydrolysates (&#x02264;3 kDa) [<xref rid="B42-marinedrugs-17-00030" ref-type="bibr">42</xref>].</p></sec><sec id="sec2dot3dot4-marinedrugs-17-00030"><title>2.3.4. Effect of SCSP on TNF-&#x003b1;, IL-1&#x003b2; and IL-6 Levels</title><p>Macrophage activation is one of the most important steps in anti-infection inflammatory responses and immune responses. Activated macrophages directly kill and eliminate pathogens and foreign substances via phagocytosis when stimulated by invasion or damaged by exogenous pathogens. Subsequently, iNOS is induced and NO is released, whereas pro-inflammatory cytokines and inflammatory molecules such as peptide growth factor (PGF), interleukin (IL), tumor necrosis factor (TNF), platelet-derived growth factor (PDG), and NO are secreted during immune response [<xref rid="B43-marinedrugs-17-00030" ref-type="bibr">43</xref>]. Considering the important role of cytokines in mediating and modulating immune and inflammatory responses, we assessed the immunomodulatory effects of SCSP by determining the secretion of TNF-&#x003b1;, IL-1&#x003b2;, and IL-6 by RAW 264.7 cells. The release of TNF-&#x003b1; was promoted in SCSP-treated RAW 264.7 cells in a dose-dependent manner, with significant increase in TNF-&#x003b1; level at 100 &#x003bc;g/mL SCSP (<xref ref-type="fig" rid="marinedrugs-17-00030-f007">Figure 7</xref>c). Furthermore, IL-6 and IL-1&#x003b2; secretion was significantly enhanced by SCSP-treatment (<xref ref-type="fig" rid="marinedrugs-17-00030-f007">Figure 7</xref>d). Previous studies on innate immune modulators have emphasized the effects of heteropolysaccharides isolated from Smilax <italic>glabra Roxb</italic> [<xref rid="B44-marinedrugs-17-00030" ref-type="bibr">44</xref>], polysaccharide ASKP-1 purified from <italic>Artemisia sphaerocephala Krasch</italic> seed [<xref rid="B45-marinedrugs-17-00030" ref-type="bibr">45</xref>], and the immunomodulatory protein PEP 1b from <italic>Pleurotus eryngii</italic> [<xref rid="B46-marinedrugs-17-00030" ref-type="bibr">46</xref>] on macrophage activation and secretion of IL-6, TNF-&#x003b1;, and IL-1&#x003b2;. These results indicated that SCSP displays significant immunomodulatory activities as it increases the secretion of NO, IL-6, IL-1&#x003b2;, and TNF-&#x003b1; in RAW 264.7 cells.</p></sec><sec id="sec2dot3dot5-marinedrugs-17-00030"><title>2.3.5. Effect of SCSP on NF-&#x003ba;B and NLRP3</title><p>NF-&#x003ba;B is an indispensable transcription factor that regulates inflammatory gene expression and immune system function, and plays a vital role in inflammatory and immune responses [<xref rid="B47-marinedrugs-17-00030" ref-type="bibr">47</xref>]. I&#x003ba;B is an important member of the NF-&#x003ba;B signaling pathway and is responsible for regulating NF-&#x003ba;B activation and transcription. Among the I&#x003ba;B family proteins, I&#x003ba;B&#x003b1; mainly mediates basal inhibition of NF-&#x003ba;B activity [<xref rid="B48-marinedrugs-17-00030" ref-type="bibr">48</xref>]. The NF-&#x003ba;B dimer binds to the inhibitory protein I&#x003ba;B&#x003b1;, which sequesters the dimer in the cytoplasm in an inactive state in resting cells. However, when various stimulating factors (such as LPS, viral protein, oxygen free radicals, pro-inflammatory cytokines) stimulate cells, the cascade signal rapidly activates I&#x003ba;B kinase (IKK). Activated IKK phosphorylates Ser-32 and Ser-36 of I&#x003ba;B. Phosphorylated I&#x003ba;B-&#x003b1; is ubiquitinated by ubiquitin conjugation enzyme and is subsequently degraded by the proteasome, releasing NF-&#x003ba;B. Activated NF-&#x003ba;B enters the nucleus and regulates transcription of genes involved in immunity and inflammation (such as iNOS, TNF-&#x003b1;, IL-1&#x003b2;, and IL-6). As shown in <xref ref-type="fig" rid="marinedrugs-17-00030-f008">Figure 8</xref>b, the NF-&#x003ba;B/&#x003b2;-actin ratio dramatically increased from 0.365 &#x000b1; 0.04 (control group) to 1.669 &#x000b1; 0.08 (<italic>P</italic> &#x0003c; 0.05) after treatment with 50 &#x003bc;g/mL SCSP, whereas that of I&#x003ba;B-&#x003b1; displayed an opposite trend in a dose-dependent manner (<xref ref-type="fig" rid="marinedrugs-17-00030-f008">Figure 8</xref>a). This is because the cytoplasmic NF-&#x003ba;B translocated to the nucleus after degradation of I&#x003ba;B&#x003b1; post SCSP stimulation.</p><p>NLRP3 is the most widely studied intracellular receptor in the NOD-like receptor family [<xref rid="B49-marinedrugs-17-00030" ref-type="bibr">49</xref>]. Upon receipt of the induction signal, the apoptosis-associated speck-like protein (ASC), pro-caspase-1, and NLRP3 assemble into the NLRP3 inflammasome. The NLRP3 inflammasome activates caspase-1, which converts the pro-inflammatory cytokines pro-IL-1&#x003b2; and pro-IL-18 into IL-1&#x003b2; and IL-18, resulting in their secretion [<xref rid="B49-marinedrugs-17-00030" ref-type="bibr">49</xref>,<xref rid="B50-marinedrugs-17-00030" ref-type="bibr">50</xref>]. To investigate the effect of SCSP on NLRP3 inflammasome activation, we treated cells with LPS and 12.5, 25, and 50 &#x003bc;g/mL SCSP and determined the protein level of NLRP3 (<italic>P</italic> &#x0003c; 0.05). Our results illustrated that 50 &#x003bc;g/mL SCSP significantly promoted the expression of NLRP3, similar to that observed for LPS-treated RAW 264.7 cells (<italic>P</italic> &#x0003c; 0.05). SCSP induced the expression of NLRP3 in a dose-dependent manner. This is also evident from the increase in the levels of IL-1&#x003b2; in the supernatant obtained after SCSP treatment (<xref ref-type="fig" rid="marinedrugs-17-00030-f008">Figure 8</xref>d). Therefore, we propose that SCSP elevated the production of NO, TNF-&#x003b1;, IL-1&#x003b2;, and IL-6 in activated macrophages via the NF-&#x003ba;B and NLRP3 inflammasome signaling pathways (<xref ref-type="fig" rid="marinedrugs-17-00030-f008">Figure 8</xref>a).</p></sec></sec></sec><sec id="sec3-marinedrugs-17-00030"><title>3. Materials and Methods</title><sec id="sec3dot1-marinedrugs-17-00030"><title>3.1. Materials and Reagents</title><p><italic>Cyclina sinensis</italic> was purchased from the Laoqi market in Zhoushan China, and validated by Prof. Shenglong Zhao of Zhejiang Ocean University (Zhoushan, Zhejiang, China). Pepsin was purchased from YTHX Biotechnology Co., Ltd. (Beijing, China). Acetonitrile and trifluoroacetic acid (high-performance liquid chromatography grade) were purchased from Shanghai Weston Trading Co., Ltd. (Shanghai, China).</p><p>Dulbecco&#x02019;s modified Eagle medium (DMEM), fetal calf serum (FCS), and penicillin&#x02212;streptomycin were purchased from Gibco BRL (Grand Island, NY, USA). Lipopolysaccharide (LPS), dimethyl sulfoxide (DMSO), and 3-(4, 5-Dimethylthiazol-2-thiazolyl)-2,5-diphenyl-2<italic>H</italic>-tetrazolium bromide (MTT) kits were purchased from Sigma-Aldrich Trading Co., Ltd. (St. Louis, MO, USA). Assay kits for IL-6, IL-1&#x003b2;, TNF-&#x003b1;, and NO were all obtained from Nanjing Jiancheng Bioengineering Institute (Nanjing, China). Neutral red and <italic>N</italic>-acetyl-<sc>l</sc>-cysteine (NAC) were purchased from Beyotime Institute of Biotechnology (Shanghai, China). Antibodies against &#x003b2;-actin (cat. no. 13E5), iNOS (cat. no. D6B6S), I&#x003ba;B&#x003b1; (cat. no. 44D4), NF-&#x003ba;B p65 (cat. no. D14E12), and NLRP3 (cat. no. D4D8T) were obtained from Cell Signaling Technology (Boston, MA, USA). All other reagents used were of analytical grade.</p></sec><sec id="sec3dot2-marinedrugs-17-00030"><title>3.2. Purification of Immunomodulatory Peptide</title><p>We prepared the protein hydrolysates of <italic>Cyclina sinensis</italic> according to the method of Ye et al. [<xref rid="B21-marinedrugs-17-00030" ref-type="bibr">21</xref>], and the fraction with MW &#x0003c; 3 kDa was lyophilized using the alpha 1&#x02013;4 LD plus freeze dryer (Marin Christ, Germany) for further purification. In detail, the pretreated <italic>Cyclina sinensis</italic> was treated with pepsin for 8 h at 42 &#x000b0;C (pH 2.0, material-liquid ratio 1:10 g/mL, enzyme dosage 1600 U/g), and then the pepsin was inactivated in boiling water for 15 min and centrifuged at 12,000&#x000d7; <italic>g</italic> for 15 min at 4 &#x000b0;C, and then Cogent &#x003bc;Scale TFF ultrafiltration system (Merck Millipore, Burlington, MA, USA) with MW cut-off membranes of 3 kDa was used to separate the CSH fraction (Freeze-dried and stored at &#x02212;80 &#x000b0;C until use). The target immunomodulatory peptide was purified from protein hydrolysates of <italic>Cyclina sinensis</italic> via ion-exchange, gel filtration, and reverse phase high performance liquid chromatography. The relative proliferation rate of RAW264.7 cells was used as index to purify the immunomodulatory peptide.</p><sec id="sec3dot2dot1-marinedrugs-17-00030"><title>3.2.1. Ion-Exchange Chromatography (IEC)</title><p>The more active fraction was dispensed into 0.05 M Tris-HCl buffer, pH 7.5 (2 mL, 200 mg/mL), which was added to a pre-equilibrated DEAE Sepharose Fast Flow column (7.1 &#x000d7; 25 cm, GE Healthcare Bio-Sciences AB, Uppsala, Sweden), and stepwise eluted using ultrapure water and NaCl solution of different concentrations (0.1, 0.5 and 1.0 M) at a flow rate of 6.0 mL/min. Fractions (9 mL/tube) were collected and detected at 280 nm, which were subsequently pooled and lyophilized for determining their cell proliferation activity toward RAW 264.7 cells at a concentration of 100 &#x003bc;g/mL.</p></sec><sec id="sec3dot2dot2-marinedrugs-17-00030"><title>3.2.2. Gel Filtration Chromatography (GFC)</title><p>The fraction purified in the previous step (400 mg) was dissolved in 2 mL ultrapure water and purified using the Sephadex G-25 gel filtration column (8.0 &#x000d7; 48 cm, GE Healthcare Bio-Sciences AB, Uppsala, Sweden), which had been equilibrated previously with ultrapure water. Ultrapure water was used as an eluent at a flow rate of 1.0 mL/min; 4 mL of the eluate was collected per tube and detected at 280 nm. Three sub-fractions were collected and lyophilized for determining their cell proliferation activity toward RAW 264.7 cells at a concentration of 100 &#x003bc;g/mL.</p></sec><sec id="sec3dot2dot3-marinedrugs-17-00030"><title>3.2.3. Reverse Phase High Performance Liquid Chromatography (RP-HPLC)</title><p>The fraction with highest cell proliferation activity was further purified using RP-HPLC (Agilent 1260 HPLC with auto fraction collector system) on a ZORBAX SB-C18 (5 &#x003bc;m, 9.4 &#x000d7; 250 mm, Agilent Technologies, Santa Clara, CA, USA) column with gradient elution system based on 100% ultrapure water as solvent A and 100% acetonitrile as solvent B. The gradient procedure was initiated with 100% solvent A after 3 min of holding, decreased to 30% solvent A within 5 min, and subsequently maintained at a flow rate of 2.0 mL/min for 10 min. The purification was repeated more than 30 times at the same gradient elution condition and the single peak fraction was collected. N-EVAP112 nitrogen evaporator (Organomation Associates, Berlin, MA, USA) was used to separate acetonitrile from the eluent. After that, the fraction was lyophilized and their cell proliferation activity against RAW 264.7 cells and their amino acid sequences were determined.</p></sec></sec><sec id="sec3dot3-marinedrugs-17-00030"><title>3.3. Determination of Amino Acid Sequence and Molecular Mass</title><p>The immunomodulatory peptide was subjected to N-terminal amino acid sequencing on a PPSQ-31A protein sequencer (Shimadzu Corporation, Kyoto, Japan). The mass spectrometer (ZQ2000, Waters, Milford, MA, USA) combined with an ESI source was used to measure the MW of the final purified peptide. Based on the sequence results determined in the previous step, Mimotopes Biotechnology Co., Ltd. (Wuxi, Jiangsu, China) provided us with peptides synthesized using the Fmoc-solid phase method for subsequent experiments.</p></sec><sec id="sec3dot4-marinedrugs-17-00030"><title>3.4. Immunomodulatory Activity Analysis in RAW264.7 Cell Line</title><sec id="sec3dot4dot1-marinedrugs-17-00030"><title>3.4.1. Culture of RAW 264.7 Cells</title><p>Murine macrophage cell line RAW 264.7 was purchased from the Chinese Academy of Sciences Cell Bank (Shanghai, China). The cells were cultured in DMEM supplemented with 10% FCS containing 100 U/mL penicillin and 100 &#x003bc;g/mL streptomycin in an incubator with a humidified 5% CO<sub>2</sub> atmosphere at 37 &#x000b0;C.</p></sec><sec id="sec3dot4dot2-marinedrugs-17-00030"><title>3.4.2. Cell Viability Assay</title><p>The effects of SCSP on cell viability were determined using the MTT assay per the method described by Chen et al. [<xref rid="B51-marinedrugs-17-00030" ref-type="bibr">51</xref>]. Briefly, RAW 264.7 cells in the logarithmic growth phase were seeded in a 96-well plate (1 &#x000d7; 10<sup>4</sup> cells/mL, 200 &#x003bc;L/well) and continuously cultured for 12 h in a 5% CO<sub>2</sub> incubator (Forma 3111 CO<sub>2</sub> incubator, Thermo Forma, USA) at 37 &#x000b0;C. Then, the medium was discarded, and the cells were treated with different concentrations of SCSP (250, 100, 50, 25, 12.5, 6.25, and 3.125 &#x003bc;g/mL). LPS (1 &#x003bc;g/mL, dissolved in DMEM) and DMEM were used as the positive and control, respectively. After culturing for 36 h, 200 &#x003bc;L MTT (5 mg/mL) was added to each well and incubated for another 4 h, the supernatant was removed, 150 &#x003bc;L of DMSO was added to each well, and incubated with mild agitation in the dark for 10 min at room temperature for complete dissolution of the produced MTT formazan crystals. The optical density (<italic>OD</italic>) of each well was measured at 490 nm using an automatic microplate reader (SpectraMax M2, Molecular Devices, San Jose, CA, USA).</p><p>The relative proliferation rate (%) was computed according to the following equation:
<disp-formula id="FD1-marinedrugs-17-00030"><mml:math id="mm1"><mml:mrow><mml:mrow><mml:mrow><mml:mi>Relative</mml:mi><mml:mtext>&#x000a0;</mml:mtext><mml:mi>proliferation</mml:mi><mml:mtext>&#x000a0;</mml:mtext><mml:mi>rate</mml:mi><mml:mtext>&#x000a0;</mml:mtext></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mo>%</mml:mo><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>O</mml:mi><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>&#x02212;</mml:mo><mml:mi>O</mml:mi><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>/</mml:mo><mml:mi>O</mml:mi><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>]</mml:mo></mml:mrow><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:mrow></mml:math></disp-formula>
where <italic>OD<sub>treated</sub></italic> is the <italic>OD</italic> value of the cells treated with SCSP or LPS; <italic>OD<sub>control</sub></italic> is the <italic>OD</italic> value of the cells cultured in DMEM without treatment.</p></sec><sec id="sec3dot4dot3-marinedrugs-17-00030"><title>3.4.3. Phagocytosis of Neutral Red</title><p>We used the method described by Ren et al. [<xref rid="B52-marinedrugs-17-00030" ref-type="bibr">52</xref>] with slight modifications to determine the effects of SCSP on the phagocytosis of RAW 264.7 cells. After the cells in 96-well plates were cultured with different concentrations (100, 50, and 25 &#x003bc;g/mL) of SCSP and LPS (1 &#x003bc;g/mL) for 36 h, the cell culture medium was removed and 0.1% neutral red solution was added at 100 &#x003bc;L/well, followed by incubation for 3 h. The cells cultured in DMEM were used as blank group, which was untreated with SCSP or LPS. Excess neutral red in the culture solution was removed by washing twice with 0.01 M PBS (pH 7.4), 200 &#x003bc;L lysis solution (ethanol/acetic acid 1:1) was added per well, and the plates were shaken for 10 min at 25 &#x000b0;C. The <italic>OD</italic> of each well was measured at 540 nm using a microplate reader.</p><p>The phagocytosis rate was calculated using the following equation:
<disp-formula id="FD2-marinedrugs-17-00030"><mml:math id="mm2"><mml:mrow><mml:mrow><mml:mrow><mml:mi>Phagocytosis</mml:mi><mml:mtext>&#x000a0;</mml:mtext><mml:mi>rate</mml:mi><mml:mtext>&#x000a0;</mml:mtext></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mo>%</mml:mo><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>O</mml:mi><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>/</mml:mo><mml:mi>O</mml:mi><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:mrow></mml:math></disp-formula></p></sec><sec id="sec3dot4dot4-marinedrugs-17-00030"><title>3.4.4. Determination of Nitric Oxide (NO) and Cytokine Levels</title><p>RAW 264.7 cells were seeded in 96-well plates (1 &#x000d7; 104 cells/mL, 200 &#x003bc;L/well) and continuously cultured for 12 h. Then, the cells were cultured with different concentrations (100, 50, and 25 &#x003bc;g/mL) of SCSP and LPS (1 &#x003bc;g/mL) for 36 h, the supernatants were collected, and the NO level was determined using the NO assay kit (Microwell plate method, Nanjing Jiancheng Bioengineering Institute, Jiangsu, China). The amounts of secreted TNF-&#x003b1;, IL-6, and IL-1&#x003b2; were determined using a microplate reader and enzyme-linked immunosorbent assay (ELISA) kits (Nanjing Jiancheng Bioengineering Institute, Jiangsu, China) according to the fabricator&#x02019;s instructions.</p></sec><sec id="sec3dot4dot5-marinedrugs-17-00030"><title>3.4.5. Western Blot Analysis</title><p>We followed the methods described in Juan Du et al. [<xref rid="B53-marinedrugs-17-00030" ref-type="bibr">53</xref>] to measure the proteins levels of iNOS, I&#x003ba;B-&#x003b1;, NF-&#x003ba;B and NLRP3 using western blotting. Total protein of the treated cells was extracted using RIPA lysis buffer, and protein concentration was measured using a bicinchoninic acid (BCA) protein quantification kit (Solarbio, Beijing, China). The proteins were separated using 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), transferred to a polyvinylidene fluoride (PVDF) membrane (Millipore, Billerica, MA, USA). Subsequently, the membrane was blocked with 10% non-fat milk for 1.5 h. The PVDF membrane was incubated with diluted specific primary antibodies against iNOS, I&#x003ba;B-&#x003b1;, NF-&#x003ba;B, and NLRP3 at 4 &#x000b0;C with gentle shaking overnight and washed thrice using Tris-buffered saline (TBS) plus Tween-20 (TBST). Finally, the PVDF membrane was incubated with the corresponding secondary antibody (horseradish peroxidase-conjugated goat-anti-rabbit, 1:3000) for 2 h. The intensity of specific bands was detected using enhanced chemiluminescence (ECL) kit and quantified using the Quantity One software (version 4.62). Band intensities were normalized to that of the loading control (&#x003b2;-actin).</p></sec></sec><sec id="sec3dot5-marinedrugs-17-00030"><title>3.5. Statistical Analysis</title><p>All experimental data were expressed as the mean &#x000b1; standard deviation of at least three independent experiments. Data were analyzed using one-way analysis of variance (ANOVA) of the SPSS software, version 19.0 (SPSS Inc., Chicago, IL, USA). The least significant difference (LSD) was used for post hoc multiple comparisons, and <italic>P</italic> &#x0003c; 0.05 was considered statistically significant for all tests.</p></sec></sec><sec id="sec4-marinedrugs-17-00030"><title>4. Conclusions</title><p>In conclusion, a novel immunomodulatory pentadecapeptide was obtained from the protein hydrolysates of <italic>Cyclina sinensis</italic> using ultrafiltration and chromatographic techniques, and its amino acid sequence was identified to be Arg-Val-Ala-Pro-Glu-Glu-His-Pro-Val-Glu-Gly-Arg-Tyr-Leu-Val (RVAPEEHPVEGRYLV) using automatic Edman degradation. Similar to most peptides with good immunomodulatory activity, the termini of the pentadecapeptide are rich in basic and hydrophobic amino acids, which may explain its immunomodulatory effects. Phagocytosis of RAW264.7 cells was significantly stimulated in a dose-dependent manner. Nitrate reductase assay and western blotting showed that SCSP increased iNOS expression and NO production. Furthermore, TNF-&#x003b1;, IL-1&#x003b2;, and IL-6 levels were elevated. The release of NF-&#x003ba;B from I&#x003ba;B-&#x003b1; was increased, consistent with the protein levels of NLRP3 after SCSP treatment. This suggested that SCSP induced macrophage activation to exert immunomodulatory effects, with the activation of the NF-&#x003ba;B and NLRP3 inflammasome signaling pathways (<xref ref-type="fig" rid="marinedrugs-17-00030-f009">Figure 9</xref>). To validate the current observations, the detailed molecular mechanisms of immunomodulation and their in vivo physiological functions will be investigated in the future. Overall, our results indicated that the immunomodulatory peptide SCSP can be a good candidate for functional foods or dietary supplements.</p></sec></body><back><notes><title>Author Contributions</title><p>F.Y. and Y.T. conceived and designed the experiments. W.L., S.Y., Z.Z. and F.H. performed the experiments. Data analysis was conducted J.T., H.J. and Z.Y. The paper was written by Y.C., G.D. and F.Y.</p></notes><notes><title>Funding</title><p>This work was financially supported by the National Natural Science Foundation of China (grant No. 21502170 and No. 41806153), the Natural Science Foundation of Zhejiang Province (grant No. LQ16H300001 and No. LQ18B060004).</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-marinedrugs-17-00030"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chalamaiah</surname><given-names>M.</given-names></name><name><surname>Hemalatha</surname><given-names>R.</given-names></name><name><surname>Jyothirmayi</surname><given-names>T.</given-names></name><name><surname>Diwan</surname><given-names>P.V.</given-names></name><name><surname>Kumar</surname><given-names>P.U.</given-names></name><name><surname>Nimgulkar</surname><given-names>C.</given-names></name><name><surname>Kumar</surname><given-names>B.D.</given-names></name></person-group><article-title>Immunomodulatory effects of protein hydrolysates from rohu (<italic>Labeo rohita</italic>) egg (roe) in BALB/c mice</article-title><source>Food Res. Int.</source><year>2014</year><volume>62</volume><fpage>1054</fpage><lpage>1061</lpage><pub-id pub-id-type="doi">10.1016/j.foodres.2014.05.050</pub-id></element-citation></ref><ref id="B2-marinedrugs-17-00030"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ketha</surname><given-names>K.</given-names></name><name><surname>Gudipati</surname><given-names>M.</given-names></name></person-group><article-title>Purification, structural characterization of an arabinogalactan from green gram (<italic>Vigna radiata</italic>) and its role in macrophage activation</article-title><source>J. Funct. Foods</source><year>2018</year><volume>50</volume><fpage>127</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1016/j.jff.2018.09.029</pub-id></element-citation></ref><ref id="B3-marinedrugs-17-00030"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.K.</given-names></name><name><surname>He</surname><given-names>H.L.</given-names></name><name><surname>Wang</surname><given-names>G.F.</given-names></name><name><surname>Wu</surname><given-names>H.</given-names></name><name><surname>Zhou</surname><given-names>B.C.</given-names></name><name><surname>Chen</surname><given-names>X.L.</given-names></name><name><surname>Zhang</surname><given-names>Y.Z.</given-names></name></person-group><article-title>Oyster (<italic>Crassostrea gigas</italic>) hydrolysates produced on a plant scale have antitumor activity and immunostimulating effects in BALB/c mice</article-title><source>Mar. Drugs</source><year>2010</year><volume>8</volume><fpage>255</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.3390/md8020255</pub-id><?supplied-pmid 20390104?><pub-id pub-id-type="pmid">20390104</pub-id></element-citation></ref><ref id="B4-marinedrugs-17-00030"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chalamaiah</surname><given-names>M.</given-names></name><name><surname>Yu</surname><given-names>W.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name></person-group><article-title>Immunomodulatory and anticancer protein hydrolysates (peptides) from food proteins: A review</article-title><source>Food Chem.</source><year>2017</year><volume>245</volume><fpage>205</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2017.10.087</pub-id><?supplied-pmid 29287362?><pub-id pub-id-type="pmid">29287362</pub-id></element-citation></ref><ref id="B5-marinedrugs-17-00030"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>W.</given-names></name><name><surname>Field</surname><given-names>C.J.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name></person-group><article-title>Purification and identification of anti-inflammatory peptides from spent hen muscle proteins hydrolysate</article-title><source>Food Chem.</source><year>2018</year><volume>253</volume><fpage>101</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2018.01.093</pub-id><?supplied-pmid 29502808?><pub-id pub-id-type="pmid">29502808</pub-id></element-citation></ref><ref id="B6-marinedrugs-17-00030"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S.K.</given-names></name><name><surname>Ngo</surname><given-names>D.H.</given-names></name><name><surname>Vo</surname><given-names>T.S.</given-names></name></person-group><article-title>Marine fish-derived bioactive peptides as potential antihypertensive agents</article-title><source>Adv. Food Nutr. Res.</source><year>2012</year><volume>65</volume><fpage>249</fpage><lpage>260</lpage><pub-id pub-id-type="pmid">22361192</pub-id></element-citation></ref><ref id="B7-marinedrugs-17-00030"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neves</surname><given-names>A.C.</given-names></name><name><surname>Harnedy</surname><given-names>P.A.</given-names></name><name><surname>O&#x02019;Keeffe</surname><given-names>M.B.</given-names></name><name><surname>FitzGerald</surname><given-names>R.J.</given-names></name></person-group><article-title>Bioactive peptides from Atlantic salmon (<italic>Salmo salar</italic>) with angiotensin converting enzyme and dipeptidyl peptidase IV inhibitory, and antioxidant activities</article-title><source>Food Chem.</source><year>2017</year><volume>218</volume><fpage>396</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2016.09.053</pub-id><pub-id pub-id-type="pmid">27719926</pub-id></element-citation></ref><ref id="B8-marinedrugs-17-00030"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Luo</surname><given-names>L.</given-names></name><name><surname>Zhu</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>F.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Tang</surname><given-names>Y.</given-names></name><name><surname>Ding</surname><given-names>G.</given-names></name></person-group><article-title>Identification and Molecular Docking Study of a Novel Angiotensin-I Converting Enzyme Inhibitory Peptide Derived from Enzymatic Hydrolysates of <italic>Cyclina sinensis</italic></article-title><source>Mar. Drugs</source><year>2018</year><volume>16</volume><elocation-id>411</elocation-id><pub-id pub-id-type="doi">10.3390/md16110411</pub-id></element-citation></ref><ref id="B9-marinedrugs-17-00030"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>F.</given-names></name><name><surname>Jing</surname><given-names>Y.</given-names></name><name><surname>Ding</surname><given-names>G.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name></person-group><article-title>Isolation and purification of novel peptides derived from Sepia ink: Effects on apoptosis of prostate cancer cell PC-3</article-title><source>Mol. Med. Res.</source><year>2017</year><volume>16</volume><fpage>4222</fpage><pub-id pub-id-type="doi">10.3892/mmr.2017.7068</pub-id></element-citation></ref><ref id="B10-marinedrugs-17-00030"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>X.</given-names></name><name><surname>Zhao</surname><given-names>Y.Q.</given-names></name><name><surname>Hu</surname><given-names>F.Y.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name></person-group><article-title>Preparation and identification of antioxidant peptides from protein hydrolysate of skate (<italic>Raja porosa</italic>) cartilage</article-title><source>J. Funct. Foods</source><year>2016</year><volume>25</volume><fpage>220</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1016/j.jff.2016.06.008</pub-id></element-citation></ref><ref id="B11-marinedrugs-17-00030"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neves</surname><given-names>A.C.</given-names></name><name><surname>Harnedy</surname><given-names>P.A.</given-names></name><name><surname>O&#x02019;Keeffe</surname><given-names>M.B.</given-names></name><name><surname>Alashi</surname><given-names>M.A.</given-names></name><name><surname>Aluko</surname><given-names>R.E.</given-names></name><name><surname>FitzGerald</surname><given-names>R.J.</given-names></name></person-group><article-title>Peptide identification in a salmon gelatin hydrolysate with antihypertensive, dipeptidyl peptidase IV inhibitory and antioxidant activities</article-title><source>Food Res. Int.</source><year>2017</year><volume>100</volume><fpage>112</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1016/j.foodres.2017.06.065</pub-id><?supplied-pmid 28873669?><pub-id pub-id-type="pmid">28873669</pub-id></element-citation></ref><ref id="B12-marinedrugs-17-00030"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y.Q.</given-names></name><name><surname>Zeng</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>Z.S.</given-names></name><name><surname>Huang</surname><given-names>F.F.</given-names></name><name><surname>Ding</surname><given-names>G.F.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name></person-group><article-title>Anti-Fatigue Effect by Peptide Fraction from Protein Hydrolysate of Croceine Croaker (<italic>Pseudosciaena crocea</italic>) Swim Bladder through Inhibiting the Oxidative Reactions including DNA Damage</article-title><source>Mar. Drugs</source><year>2016</year><volume>14</volume><elocation-id>221</elocation-id><pub-id pub-id-type="doi">10.3390/md14120221</pub-id><?supplied-pmid 27983570?><pub-id pub-id-type="pmid">27983570</pub-id></element-citation></ref><ref id="B13-marinedrugs-17-00030"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santiago-L&#x000f3;pez</surname><given-names>L.</given-names></name><name><surname>Hern&#x000e1;ndez-Mendoza</surname><given-names>A.</given-names></name><name><surname>Vallejo-Cordoba</surname><given-names>B.</given-names></name><name><surname>Mata-Haro</surname><given-names>V.</given-names></name><name><surname>Gonz&#x000e1;lez-C&#x000f3;rdova</surname><given-names>A.F.</given-names></name></person-group><article-title>Food-derived immunomodulatory peptides</article-title><source>J. Sci. Food Agric.</source><year>2016</year><volume>96</volume><fpage>3631</fpage><lpage>3641</lpage><pub-id pub-id-type="doi">10.1002/jsfa.7697</pub-id><?supplied-pmid 26940008?><pub-id pub-id-type="pmid">26940008</pub-id></element-citation></ref><ref id="B14-marinedrugs-17-00030"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>H.</given-names></name><name><surname>Fan</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Xue</surname><given-names>C.</given-names></name><name><surname>Yu</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name></person-group><article-title>Purification and identification of immunomodulating peptides from enzymatic hydrolysates of Alaska pollock frame</article-title><source>Food Chem.</source><year>2012</year><volume>134</volume><fpage>821</fpage><lpage>828</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2012.02.186</pub-id><?supplied-pmid 23107696?><pub-id pub-id-type="pmid">23107696</pub-id></element-citation></ref><ref id="B15-marinedrugs-17-00030"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Ren</surname><given-names>Y.</given-names></name><name><surname>Cai</surname><given-names>X.</given-names></name><name><surname>Yin</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Min</surname><given-names>T.</given-names></name><name><surname>Wu</surname><given-names>H.</given-names></name></person-group><article-title>Characterization and Immunomodulatory Activity of a Novel Peptide, ECFSTA, from Wheat Germ Globulin</article-title><source>J. Agric. Food Chem.</source><year>2017</year><volume>65</volume><fpage>5561</fpage><lpage>5569</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.7b01360</pub-id><?supplied-pmid 28635255?><pub-id pub-id-type="pmid">28635255</pub-id></element-citation></ref><ref id="B16-marinedrugs-17-00030"><label>16.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Chinese Animal Science Editorial Board of Chinese Academy of Sciences</collab></person-group><source>Chinese Zoology, Mollusc, Bivalve, Curcuma</source><publisher-name>Science Press</publisher-name><publisher-loc>Beijing, China</publisher-loc><year>2001</year></element-citation></ref><ref id="B17-marinedrugs-17-00030"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Dong</surname><given-names>Z.</given-names></name><name><surname>Yan</surname><given-names>B.</given-names></name><name><surname>Cheng</surname><given-names>H.</given-names></name><name><surname>Meng</surname><given-names>X.</given-names></name><name><surname>Shen</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name></person-group><article-title>Analysis and evaluation of nutritional components in <italic>cyclina sinensis</italic> and meretrix meretrix</article-title><source>Food Sci.</source><year>2010</year><volume>31</volume><fpage>366</fpage><lpage>370</lpage><comment>(In Chinese)</comment></element-citation></ref><ref id="B18-marinedrugs-17-00030"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>C.</given-names></name><name><surname>Xiong</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Zeng</surname><given-names>X.</given-names></name></person-group><article-title>Structural characterization, sulfation and antitumor activity of a polysaccharide fraction from <italic>Cyclina sinensis</italic></article-title><source>Carbohydr. Polym.</source><year>2015</year><volume>115</volume><fpage>200</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2014.08.095</pub-id><pub-id pub-id-type="pmid">25439886</pub-id></element-citation></ref><ref id="B19-marinedrugs-17-00030"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>C.</given-names></name><name><surname>Xiong</surname><given-names>Q.</given-names></name><name><surname>Gan</surname><given-names>D.</given-names></name><name><surname>Jiao</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Ma</surname><given-names>L.</given-names></name><name><surname>Zeng</surname><given-names>X.</given-names></name></person-group><article-title>Antioxidant activity and potential hepatoprotective effect of polysaccharides from <italic>Cyclina sinensis</italic></article-title><source>Carbohydr. Polym.</source><year>2013</year><volume>91</volume><fpage>262</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2012.08.029</pub-id><pub-id pub-id-type="pmid">23044131</pub-id></element-citation></ref><ref id="B20-marinedrugs-17-00030"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>Y.</given-names></name><name><surname>Pan</surname><given-names>H.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Pan</surname><given-names>B.</given-names></name><name><surname>Bu</surname><given-names>W.</given-names></name></person-group><article-title>Molecular cloning, characterization and functional analysis of a heat shock protein 70 gene in <italic>Cyclina sinensis</italic></article-title><source>Fish Shellfish Immunol.</source><year>2016</year><volume>58</volume><fpage>663</fpage><lpage>668</lpage><pub-id pub-id-type="doi">10.1016/j.fsi.2016.10.009</pub-id><pub-id pub-id-type="pmid">27725261</pub-id></element-citation></ref><ref id="B21-marinedrugs-17-00030"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Tang</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Yu</surname><given-names>F.</given-names></name><name><surname>Ding</surname><given-names>G.</given-names></name></person-group><article-title>Immunomodulatory Effects of Enzymatic Peptides from <italic>Cyclina Sinensis</italic> on RAW264.7 Macrophages</article-title><source>Food Sci.</source><year>2018</year><comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.spkx.net.cn/CN/abstract/abstract44136.shtml">http://www.spkx.net.cn/CN/abstract/abstract44136.shtml</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2018-04-04">(accessed on 4 April 2018)</date-in-citation><comment>(In Chinese)</comment></element-citation></ref><ref id="B22-marinedrugs-17-00030"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Liu</surname><given-names>C.</given-names></name><name><surname>Meng</surname><given-names>Y.</given-names></name><name><surname>Hou</surname><given-names>Q.</given-names></name><name><surname>Sheng</surname><given-names>M.</given-names></name></person-group><article-title>Quantitative study of the effects of <italic>Cyclina Sinensis</italic> flesh extract on the &#x003b1;-naphthyl esterase activity of lymphocytes in the immune organs of aged rats</article-title><source>Chin. J. Conv. Med.</source><year>1997</year><volume>1</volume><fpage>38</fpage><lpage>40</lpage></element-citation></ref><ref id="B23-marinedrugs-17-00030"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Ye</surname><given-names>L.</given-names></name><name><surname>Tang</surname><given-names>Y.</given-names></name><name><surname>Ding</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name></person-group><article-title>A novel anti-proliferative pentapeptide (ILYMP) isolated from <italic>Cyclina sinensis</italic> protein hydrolysate induces apoptosis of DU-145 prostate cancer cells</article-title><source>Mol. Med. Rep.</source><year>2018</year><volume>18</volume><fpage>771</fpage><lpage>778</lpage><?supplied-pmid 29767237?><pub-id pub-id-type="pmid">29767237</pub-id></element-citation></ref><ref id="B24-marinedrugs-17-00030"><label>24.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Jarrous</surname><given-names>N.</given-names></name><name><surname>Altman</surname><given-names>S.</given-names></name></person-group><article-title>[9]&#x02014;Human Ribonuclease P</article-title><source>Methods in Enzymology</source><person-group person-group-type="editor"><name><surname>Nicholson</surname><given-names>A.W.</given-names></name></person-group><publisher-name>Academic Press</publisher-name><publisher-loc>Cambridge, MA, USA</publisher-loc><year>2001</year><volume>Volume 342</volume><fpage>93</fpage><lpage>100</lpage></element-citation></ref><ref id="B25-marinedrugs-17-00030"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>X.</given-names></name><name><surname>Guo</surname><given-names>M.</given-names></name><name><surname>Hua</surname><given-names>Y.</given-names></name><name><surname>Cao</surname><given-names>D.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name></person-group><article-title>Enzymatic preparation of immunomodulating hydrolysates from soy proteins</article-title><source>Bioresour. Technol.</source><year>2008</year><volume>99</volume><fpage>8873</fpage><lpage>8879</lpage><pub-id pub-id-type="doi">10.1016/j.biortech.2008.04.056</pub-id><?supplied-pmid 18524579?><pub-id pub-id-type="pmid">18524579</pub-id></element-citation></ref><ref id="B26-marinedrugs-17-00030"><label>26.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Duong-Ly</surname><given-names>K.C.</given-names></name><name><surname>Gabelli</surname><given-names>S.B.</given-names></name></person-group><article-title>Chapter Nine&#x02014;Gel Filtration Chromatography (Size Exclusion Chromatography) of Proteins</article-title><source>Methods in Enzymology</source><person-group person-group-type="editor"><name><surname>Lorsch</surname><given-names>J.</given-names></name></person-group><publisher-name>Academic Press</publisher-name><publisher-loc>Cambridge, MA, USA</publisher-loc><year>2014</year><volume>Volume 541</volume><fpage>105</fpage><lpage>114</lpage></element-citation></ref><ref id="B27-marinedrugs-17-00030"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Sun</surname><given-names>C.</given-names></name><name><surname>Brennan</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Lai</surname><given-names>F.</given-names></name><name><surname>Wu</surname><given-names>H.</given-names></name></person-group><article-title>Enzymatic preparation of immunomodulatory hydrolysates from defatted wheat germ (<italic>Triticum Vulgare</italic>) globulin</article-title><source>Int. J. Food Sci. Technol.</source><year>2016</year><volume>51</volume><fpage>2556</fpage><lpage>2566</lpage><pub-id pub-id-type="doi">10.1111/ijfs.13238</pub-id></element-citation></ref><ref id="B28-marinedrugs-17-00030"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacquot</surname><given-names>A.</given-names></name><name><surname>Gauthier</surname><given-names>S.F.</given-names></name><name><surname>Drouin</surname><given-names>R.</given-names></name><name><surname>Boutin</surname><given-names>Y.</given-names></name></person-group><article-title>Proliferative effects of synthetic peptides from &#x003b2;-lactoglobulin and &#x003b1;-lactalbumin on murine splenocytes</article-title><source>Intl. Dairy J.</source><year>2010</year><volume>20</volume><fpage>514</fpage><lpage>521</lpage><pub-id pub-id-type="doi">10.1016/j.idairyj.2010.02.013</pub-id></element-citation></ref><ref id="B29-marinedrugs-17-00030"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mercier</surname><given-names>A.</given-names></name><name><surname>Gauthier</surname><given-names>S.F.</given-names></name><name><surname>Fliss</surname><given-names>I.</given-names></name></person-group><article-title>Immunomodulating effects of whey proteins and their enzymatic digests</article-title><source>Int. Dairy J.</source><year>2004</year><volume>14</volume><fpage>175</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1016/j.idairyj.2003.08.003</pub-id></element-citation></ref><ref id="B30-marinedrugs-17-00030"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H.M.</given-names></name><name><surname>Muramoto</surname><given-names>K.</given-names></name><name><surname>Yamauchi</surname><given-names>F.</given-names></name></person-group><article-title>Structural analysis of antioxidative peptides from soybean beta-conglycinin</article-title><source>J. Agric. Food Chem.</source><year>1995</year><volume>43</volume><fpage>574</fpage><lpage>578</lpage><pub-id pub-id-type="doi">10.1021/jf00051a004</pub-id></element-citation></ref><ref id="B31-marinedrugs-17-00030"><label>31.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Pixley</surname><given-names>F.J.</given-names></name></person-group><article-title>Tumor-Associated Macrophages</article-title><source>Reference Module in Biomedical Sciences</source><publisher-name>Elsevier</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2018</year></element-citation></ref><ref id="B32-marinedrugs-17-00030"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Xie</surname><given-names>J.</given-names></name><name><surname>Jia</surname><given-names>S.</given-names></name><name><surname>Huang</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Xie</surname><given-names>M.</given-names></name></person-group><article-title>Immunomodulatory effects of an acetylated Cyclocarya paliurus polysaccharide on murine macrophages RAW264.7</article-title><source>Int. J. Biol. Macromol.</source><year>2017</year><volume>98</volume><fpage>576</fpage><lpage>581</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2017.02.028</pub-id><pub-id pub-id-type="pmid">28192134</pub-id></element-citation></ref><ref id="B33-marinedrugs-17-00030"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>J.F.</given-names></name><name><surname>Zha</surname><given-names>X.Q.</given-names></name><name><surname>Cui</surname><given-names>S.H.</given-names></name><name><surname>Cao</surname><given-names>L.</given-names></name><name><surname>Luo</surname><given-names>J.P.</given-names></name></person-group><article-title>Immunomodulatory activity on macrophage of a purified polysaccharide extracted from <italic>Laminaria japonica</italic></article-title><source>Carbohydr. Polym.</source><year>2015</year><volume>134</volume><fpage>66</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2015.07.070</pub-id><pub-id pub-id-type="pmid">26428101</pub-id></element-citation></ref><ref id="B34-marinedrugs-17-00030"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>S.</given-names></name></person-group><article-title>Phagocytosis: An Immunobiologic Process</article-title><source>Immunity</source><year>2016</year><volume>44</volume><fpage>463</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2016.02.026</pub-id><pub-id pub-id-type="pmid">26982354</pub-id></element-citation></ref><ref id="B35-marinedrugs-17-00030"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di</surname><given-names>T.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Ou</surname><given-names>S.</given-names></name><name><surname>Zeng</surname><given-names>X.</given-names></name><name><surname>Ye</surname><given-names>H.</given-names></name></person-group><article-title>Antioxidant and immunostimulating activities in vitro of sulfated polysaccharides isolated from Gracilaria rubra</article-title><source>J. Funct. Foods</source><year>2017</year><volume>28</volume><fpage>64</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1016/j.jff.2016.11.005</pub-id></element-citation></ref><ref id="B36-marinedrugs-17-00030"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>D.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Ma</surname><given-names>S.</given-names></name><name><surname>Cui</surname><given-names>L.</given-names></name><name><surname>Huang</surname><given-names>S.</given-names></name><name><surname>Sheng</surname><given-names>X.</given-names></name><name><surname>Weng</surname><given-names>Q.</given-names></name><name><surname>Xu</surname><given-names>M.</given-names></name></person-group><article-title>Immunostimulatory activity of protein hydrolysate from oviductus ranae on macrophage in vitro</article-title><source>Evid.-Based Complement. Altern. Med.</source><year>2014</year><volume>2014</volume><fpage>180234</fpage><pub-id pub-id-type="doi">10.1155/2014/180234</pub-id><?supplied-pmid 25610475?><pub-id pub-id-type="pmid">25610475</pub-id></element-citation></ref><ref id="B37-marinedrugs-17-00030"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>H.</given-names></name><name><surname>Fan</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Xue</surname><given-names>C.</given-names></name><name><surname>Yu</surname><given-names>G.</given-names></name></person-group><article-title>Preparation of immunomodulatory hydrolysates from Alaska pollock frame</article-title><source>J. Sci. Food Agric.</source><year>2012</year><volume>92</volume><fpage>3029</fpage><lpage>3038</lpage><pub-id pub-id-type="doi">10.1002/jsfa.5719</pub-id><?supplied-pmid 22576701?><pub-id pub-id-type="pmid">22576701</pub-id></element-citation></ref><ref id="B38-marinedrugs-17-00030"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coleman</surname><given-names>J.W.</given-names></name></person-group><article-title>Nitric oxide in immunity and inflammation</article-title><source>Int. Immunopharmacol.</source><year>2001</year><volume>1</volume><fpage>1397</fpage><lpage>1406</lpage><pub-id pub-id-type="doi">10.1016/S1567-5769(01)00086-8</pub-id><pub-id pub-id-type="pmid">11515807</pub-id></element-citation></ref><ref id="B39-marinedrugs-17-00030"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daff</surname><given-names>S.</given-names></name></person-group><article-title>NO synthase: Structures and mechanisms</article-title><source>Nitric Oxide</source><year>2010</year><volume>23</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.niox.2010.03.001</pub-id><?supplied-pmid 20303412?><pub-id pub-id-type="pmid">20303412</pub-id></element-citation></ref><ref id="B40-marinedrugs-17-00030"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fitzpatrick</surname><given-names>B.</given-names></name><name><surname>Mehibel</surname><given-names>M.</given-names></name><name><surname>Cowen</surname><given-names>R.L.</given-names></name><name><surname>Stratford</surname><given-names>I.J.</given-names></name></person-group><article-title>iNOS as a therapeutic target for treatment of human tumors</article-title><source>Nitric Oxide</source><year>2008</year><volume>19</volume><fpage>217</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1016/j.niox.2008.05.001</pub-id><?supplied-pmid 18515106?><pub-id pub-id-type="pmid">18515106</pub-id></element-citation></ref><ref id="B41-marinedrugs-17-00030"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ndiaye</surname><given-names>F.</given-names></name><name><surname>Vuong</surname><given-names>T.</given-names></name><name><surname>Duarte</surname><given-names>J.</given-names></name><name><surname>Aluko</surname><given-names>R.E.</given-names></name><name><surname>Matar</surname><given-names>C.</given-names></name></person-group><article-title>Anti-oxidant, anti-inflammatory and immunomodulating properties of an enzymatic protein hydrolysate from yellow field pea seeds</article-title><source>Eur. J. Nutr.</source><year>2012</year><volume>51</volume><fpage>29</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1007/s00394-011-0186-3</pub-id><?supplied-pmid 21442413?><pub-id pub-id-type="pmid">21442413</pub-id></element-citation></ref><ref id="B42-marinedrugs-17-00030"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Ji</surname><given-names>H.</given-names></name><name><surname>Ma</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name></person-group><article-title>Immunomodulatory activity of small molecular (&#x02264;3 kDa) Coix glutelin enzymatic hydrolysate</article-title><source>CyTA J. Food</source><year>2017</year><volume>15</volume><fpage>41</fpage><lpage>48</lpage></element-citation></ref><ref id="B43-marinedrugs-17-00030"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schultze</surname><given-names>J.L.</given-names></name><name><surname>Schmidt</surname><given-names>S.V.</given-names></name></person-group><article-title>Molecular features of macrophage activation</article-title><source>Semin. Immunol.</source><year>2015</year><volume>27</volume><fpage>416</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1016/j.smim.2016.03.009</pub-id><?supplied-pmid 27049460?><pub-id pub-id-type="pmid">27049460</pub-id></element-citation></ref><ref id="B44-marinedrugs-17-00030"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Yang</surname><given-names>X.B.</given-names></name><name><surname>Zhao</surname><given-names>J.W.</given-names></name><name><surname>Lu</surname><given-names>C.J.</given-names></name><name><surname>Zhu</surname><given-names>W.</given-names></name></person-group><article-title>Structural characterization and macrophage immunomodulatory activity of a novel polysaccharide from Smilax glabra Roxb</article-title><source>Carbohydr. Polym.</source><year>2017</year><volume>156</volume><fpage>390</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2016.09.033</pub-id><?supplied-pmid 27842838?><pub-id pub-id-type="pmid">27842838</pub-id></element-citation></ref><ref id="B45-marinedrugs-17-00030"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>D.</given-names></name><name><surname>Lin</surname><given-names>D.</given-names></name><name><surname>Alim</surname><given-names>A.</given-names></name><name><surname>Zheng</surname><given-names>Q.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name></person-group><article-title>Chemical characterization of a novel polysaccharide ASKP-1 from Artemisia sphaerocephala Krasch seed and its macrophage activation via MAPK, PI3k/Akt and NF-&#x003ba;B signaling pathways in RAW264.7 cells</article-title><source>Food Funct.</source><year>2017</year><volume>8</volume><fpage>1299</fpage><lpage>1312</lpage><pub-id pub-id-type="doi">10.1039/C6FO01699E</pub-id><?supplied-pmid 28251195?><pub-id pub-id-type="pmid">28251195</pub-id></element-citation></ref><ref id="B46-marinedrugs-17-00030"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Q.</given-names></name><name><surname>Du</surname><given-names>H.</given-names></name><name><surname>Ma</surname><given-names>G.</given-names></name><name><surname>Pei</surname><given-names>F.</given-names></name><name><surname>Ma</surname><given-names>N.</given-names></name><name><surname>Yuan</surname><given-names>B.</given-names></name><name><surname>Nakata</surname><given-names>P.A.</given-names></name><name><surname>Yang</surname><given-names>W.</given-names></name></person-group><article-title>Purification, identification and functional characterization of an immunomodulatory protein from <italic>Pleurotus eryngii</italic></article-title><source>Food Funct.</source><year>2018</year><volume>9</volume><fpage>3764</fpage><lpage>3775</lpage><pub-id pub-id-type="doi">10.1039/C8FO00604K</pub-id><pub-id pub-id-type="pmid">29897364</pub-id></element-citation></ref><ref id="B47-marinedrugs-17-00030"><label>47.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gilmore</surname><given-names>T.D.</given-names></name><name><surname>Siggers</surname><given-names>T.W.</given-names></name><name><surname>Gerondakis</surname><given-names>S.</given-names></name></person-group><article-title>NF-kappaB and the Immune System</article-title><source>Encyclopedia of Cell Biology</source><person-group person-group-type="editor"><name><surname>Bradshaw</surname><given-names>R.A.</given-names></name><name><surname>Stahl</surname><given-names>P.D.</given-names></name></person-group><publisher-name>Academic Press</publisher-name><publisher-loc>Waltham, MA, USA</publisher-loc><year>2016</year><fpage>580</fpage><lpage>587</lpage></element-citation></ref><ref id="B48-marinedrugs-17-00030"><label>48.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Mizgerd</surname><given-names>J.P.</given-names></name></person-group><article-title>TRANSCRIPTION FACTORS|NF-&#x003ba;B and I&#x003ba;b</article-title><source>Encyclopedia of Respiratory Medicine</source><person-group person-group-type="editor"><name><surname>Laurent</surname><given-names>G.J.</given-names></name><name><surname>Shapiro</surname><given-names>S.D.</given-names></name></person-group><publisher-name>Academic Press</publisher-name><publisher-loc>Oxford, UK</publisher-loc><year>2006</year><fpage>265</fpage><lpage>269</lpage></element-citation></ref><ref id="B49-marinedrugs-17-00030"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>H.-H.</given-names></name><name><surname>Yang</surname><given-names>Y.-X.</given-names></name><name><surname>Meng</surname><given-names>X.</given-names></name><name><surname>Luo</surname><given-names>X.-Y.</given-names></name><name><surname>Li</surname><given-names>X.-M.</given-names></name><name><surname>Shuai</surname><given-names>Z.-W.</given-names></name><name><surname>Ye</surname><given-names>D.-Q.</given-names></name><name><surname>Pan</surname><given-names>H.-F.</given-names></name></person-group><article-title>NLRP3: A promising therapeutic target for autoimmune diseases</article-title><source>Autoimmun. Rev.</source><year>2018</year><volume>17</volume><fpage>694</fpage><lpage>702</lpage><pub-id pub-id-type="doi">10.1016/j.autrev.2018.01.020</pub-id><pub-id pub-id-type="pmid">29729449</pub-id></element-citation></ref><ref id="B50-marinedrugs-17-00030"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>H.</given-names></name><name><surname>Lee</surname><given-names>C.</given-names></name><name><surname>Rhee</surname><given-names>D.</given-names></name><name><surname>Um</surname><given-names>S.</given-names></name><name><surname>Pyo</surname><given-names>S.</given-names></name></person-group><article-title>Sinigrin inhibits production of inflammatory mediators by suppressing NF-&#x003ba;B/MAPK pathways or NLRP3 inflammasome activation in macrophages</article-title><source>Int. Immunopharmacol.</source><year>2017</year><volume>45</volume><fpage>163</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2017.01.032</pub-id><?supplied-pmid 28219839?><pub-id pub-id-type="pmid">28219839</pub-id></element-citation></ref><ref id="B51-marinedrugs-17-00030"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Ji</surname><given-names>N.</given-names></name><name><surname>Pan</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>R.</given-names></name><name><surname>Qiu</surname><given-names>Y.</given-names></name><name><surname>Jin</surname><given-names>M.</given-names></name><name><surname>Kong</surname><given-names>D.</given-names></name></person-group><article-title>Roburic Acid Suppresses NO and IL-6 Production via Targeting NF-&#x003ba;B and MAPK Pathway in RAW264.7 Cells</article-title><source>Inflammation</source><year>2017</year><volume>40</volume><fpage>1959</fpage><lpage>1966</lpage><pub-id pub-id-type="doi">10.1007/s10753-017-0636-z</pub-id><?supplied-pmid 28761990?><pub-id pub-id-type="pmid">28761990</pub-id></element-citation></ref><ref id="B52-marinedrugs-17-00030"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>Y.</given-names></name><name><surname>Zheng</surname><given-names>G.</given-names></name><name><surname>You</surname><given-names>L.</given-names></name><name><surname>Wen</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Fu</surname><given-names>X.</given-names></name><name><surname>Zhou</surname><given-names>L.</given-names></name></person-group><article-title>Structural characterization and macrophage immunomodulatory activity of a polysaccharide isolated from <italic>Gracilaria lemaneiformis</italic></article-title><source>J. Funct. Foods</source><year>2017</year><volume>33</volume><fpage>286</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1016/j.jff.2017.03.062</pub-id></element-citation></ref><ref id="B53-marinedrugs-17-00030"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Zhu</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>C.</given-names></name><name><surname>Bi</surname><given-names>S.</given-names></name><name><surname>Song</surname><given-names>L.</given-names></name><name><surname>Hu</surname><given-names>X.</given-names></name><name><surname>Yu</surname><given-names>R.</given-names></name></person-group><article-title>Structural characterization and immunomodulatory activity of a novel polysaccharide from Ficus carica</article-title><source>Food Funct.</source><year>2018</year><volume>9</volume><fpage>3930</fpage><lpage>3943</lpage><pub-id pub-id-type="doi">10.1039/C8FO00603B</pub-id><pub-id pub-id-type="pmid">29974087</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="marinedrugs-17-00030-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>The peptide fraction of the <italic>Cyclina sinensis</italic> hydrolysate with MW &#x0003c; 3 kDa were purified using IEC and GFC; (<bold>a</bold>) Elution profiles of the fraction with MW &#x0003c; 3 kDa by anion exchange chromatography; (<bold>b</bold>) Effects of the elution fractions of IEC on the viability of RAW 264.7 cells; (<bold>c</bold>) Elution profiles of IEC-I by Gel filtration chromatography; (<bold>d</bold>) Effects of the elution fractions of GFC on the viability of RAW 264.7 cells; Data are presented as the mean &#x000b1; SD (n = 3). (*) Results are significantly different from the control (<italic>P</italic> &#x0003c; 0.05).</p></caption><graphic xlink:href="marinedrugs-17-00030-g001"/></fig><fig id="marinedrugs-17-00030-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Purification of fractions GFC-II using RP-HPLC; (<bold>a</bold>) Elution profiles of GFC-II by Reverse phase high-performance liquid chromatography; (<bold>b</bold>) Effects of the elution fractions of RP-HPLC on the viability of RAW 264.7 cells; Data are presented as the mean &#x000b1; SD (n = 3). (*) Results are significantly different from the control (<italic>P</italic> &#x0003c; 0.05).</p></caption><graphic xlink:href="marinedrugs-17-00030-g002"/></fig><fig id="marinedrugs-17-00030-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Purity analyze of HPLC-IV fraction by RP-HPLC.</p></caption><graphic xlink:href="marinedrugs-17-00030-g003"/></fig><fig id="marinedrugs-17-00030-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>ESI-MS spectrum of the peptide CSP; The circles of different colors in the figure represent the amino acid sequence of CSP, wherein blue represents basic amino acid, black represents hydrophobic amino acid, red represents acidic amino acid, and hydrophilic amino acids are represented by green.</p></caption><graphic xlink:href="marinedrugs-17-00030-g004"/></fig><fig id="marinedrugs-17-00030-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Effect of SCSP on macrophages viability. The significance of the subsequent data were presented as (*). Results are significantly different from the control (<italic>P</italic> &#x0003c; 0.05). (**) Results are significantly different from the control (<italic>P</italic> &#x0003c; 0.01).</p></caption><graphic xlink:href="marinedrugs-17-00030-g005"/></fig><fig id="marinedrugs-17-00030-f006" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Effect of SCSP on phagocytic activity. The significance of the subsequent data were presented as (**). Results are significantly different from the control (<italic>P</italic> &#x0003c; 0.01).</p></caption><graphic xlink:href="marinedrugs-17-00030-g006"/></fig><fig id="marinedrugs-17-00030-f007" orientation="portrait" position="float"><label>Figure 7</label><caption><p>Assessment of release of nitric oxide and cytokines by macrophages with SCSP-treated; (<bold>a</bold>) Effect of SCSP on NO production; (<bold>b</bold>) Effect of SCSP on iNOS expression; (<bold>c</bold>) Effect of SCSP on TNF-&#x003b1; secretion; (<bold>d</bold>) Effect of SCSP on IL-1&#x003b2; and IL-6 secretion. The significance of the subsequent data were presented as (*). Results are significantly different from the control (<italic>P</italic> &#x0003c; 0.05). (**) Results are significantly different from the control (<italic>P</italic> &#x0003c; 0.01).</p></caption><graphic xlink:href="marinedrugs-17-00030-g007"/></fig><fig id="marinedrugs-17-00030-f008" orientation="portrait" position="float"><label>Figure 8</label><caption><p>Effects of SCSP on the expression of I&#x003ba;B-&#x003b1;, NF-&#x003ba;B and NLRP3; (<bold>a</bold>) Western blot analysis of I&#x003ba;B-&#x003b1;, NF-&#x003ba;B and NLRP3 induced by SCSP in RAW264.7 cells; (<bold>b</bold>) Effects of SCSP on the expression of I&#x003ba;B-&#x003b1; in RAW264.7 cells; (<bold>c</bold>) Effects of SCSP on the expression of NF-&#x003ba;B in RAW264.7 cells; (<bold>d</bold>) Effects of SCSP on the expression of NLRP3 in RAW264.7 cells; The intensity of specific bands was detected by the Quantity One software (version 4.62) to quantify protein expression levels; The grayscale ratio of the specific bands and &#x003b2;-actin were presented as the mean &#x000b1; SD (n = 3) by the histogram; (*) Results are significantly different from the control (<italic>P</italic> &#x0003c; 0.05). (**) Results are significantly different from the control (<italic>P</italic> &#x0003c; 0.01).</p></caption><graphic xlink:href="marinedrugs-17-00030-g008"/></fig><fig id="marinedrugs-17-00030-f009" orientation="portrait" position="float"><label>Figure 9</label><caption><p>Possible molecular mechanisms of SCSP-induced macrophage activation.</p></caption><graphic xlink:href="marinedrugs-17-00030-g009"/></fig></floats-group></article>